CI
SZYM

Capital Innovations’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Capital Innovations’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-26,360
Closed -$197K – 96
2014
Q3 		$197K Buy
26,360
+2,400
+10% +$22.4K 0.18% 84
2014
Q2 		$282K Sell
23,960
-323
-1% -$3.44K 0.23% 69
2014
Q1 		$282K Buy
24,283
+2,105
+9% +$24.8K 0.24% 73
2013
Q4 		$241K Buy
+22,178
New +$218K 0.22% 77

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Innovations's SZYM Position: Q4 2014 in Review

Capital Innovations sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2014, closing a stake of 26,360 shares — an estimated $197K sold.

Capital Innovations first reported a position in SZYM in Q4 2013 and held it in 4 quarters. The position peaked at $282K in Q2 2014. 114 funds tracked by Wall St. Rank hold SZYM as of Q4 2014.

  • Capital Innovations reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Capital Innovations sold 26,360 SOLAZYME INC COM STK (DE) shares in Q4 2014, an estimated $197K.
  • Capital Innovations first reported a position in SOLAZYME INC COM STK (DE) in Q4 2013 and held it in 4 quarters.
  • Capital Innovations's SOLAZYME INC COM STK (DE) position peaked at $282K in Q2 2014.
  • 114 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2014.

Based on Capital Innovations's 13F filing for Q4 2014, filed 20 Jan 2015.